|Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1|
GL Carvill, SB Heavin, SC Yendle, JM McMahon, BJ O'Roak, J Cook, ...
Nature genetics 45 (7), 825-830, 2013
|Long-term follow-up of patients with thalamic deep brain stimulation for epilepsy|
DM Andrade, D Zumsteg, C Hamani, M Hodaie, S Sarkissian, AM Lozano, ...
Neurology 66 (10), 1571-1573, 2006
|High rate of recurrent de novo mutations in developmental and epileptic encephalopathies|
FF Hamdan, CT Myers, P Cossette, P Lemay, D Spiegelman, AD Laporte, ...
The American Journal of Human Genetics 101 (5), 664-685, 2017
|A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy|
M Muona, SF Berkovic, LM Dibbens, KL Oliver, S Maljevic, MA Bayly, ...
Nature genetics 47 (1), 39-46, 2015
|Practical guidelines for managing adults with 22q11. 2 deletion syndrome|
WLA Fung, NJ Butcher, G Costain, DM Andrade, E Boot, EWC Chow, ...
Genetics in Medicine 17 (8), 599-609, 2015
|Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis?|
DM Andrade, P Tai, J Dalmau, R Wennberg
Neurology 76 (15), 1355-1357, 2011
|Deep brain stimulation of the anterior nucleus of the thalamus: effects of electrical stimulation on pilocarpine-induced seizures and status epilepticus|
C Hamani, M Hodaie, J Chiang, M del Campo, DM Andrade, D Sherman, ...
Epilepsy research 78 (2-3), 117-123, 2008
|Delineating the 15q13. 3 microdeletion phenotype: a case series and comprehensive review of the literature|
C Lowther, G Costain, DJ Stavropoulos, R Melvin, CK Silversides, ...
Genetics in Medicine 17 (2), 149-157, 2015
|Ultra-rare genetic variation in the epilepsies: a whole-exome sequencing study of 17,606 individuals|
YCA Feng, DP Howrigan, LE Abbott, K Tashman, F Cerrato, T Singh, ...
The American Journal of Human Genetics 105 (2), 267-282, 2019
|Anterior nucleus deep brain stimulation for refractory epilepsy: insights into patterns of seizure control and efficacious target|
V Krishna, NKK King, F Sammartino, I Strauss, DM Andrade, ...
Neurosurgery 78 (6), 802-811, 2016
|Skin biopsy in Lafora disease: genotype–phenotype correlations and diagnostic pitfalls|
DM Andrade, CA Ackerley, TSC Minett, HAG Teive, S Bohlega, ...
Neurology 61 (11), 1611-1614, 2003
|Genetic basis in epilepsies caused by malformations of cortical development and in those with structurally normal brain|
Human genetics 126 (1), 173, 2009
|Mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) may respond to adjunctive ketogenic diet|
C Steriade, DM Andrade, H Faghfoury, MA Tarnopolsky, P Tai
Pediatric neurology 50 (5), 498-502, 2014
|Neonatal hypocalcemia, neonatal seizures, and intellectual disability in 22q11. 2 deletion syndrome|
ENM Cheung, SR George, DM Andrade, EWC Chow, CK Silversides, ...
Genetics in Medicine 16 (1), 40-44, 2014
|Laforin is a cell membrane and endoplasmic reticulum–associated protein tyrosine phosphatase|
BA Minassian, DM Andrade, L Ianzano, EJ Young, E Chan, CA Ackerley, ...
Annals of Neurology: Official Journal of the American Neurological …, 2001
|Prevalence of hypocalcaemia and its associated features in 22q11· 2 deletion syndrome|
ENM Cheung, SR George, GA Costain, DM Andrade, EWC Chow, ...
Clinical endocrinology 81 (2), 190-196, 2014
|Deep brain stimulation for the treatment of epilepsy|
C Hamani, D Andrade, M Hodaie, R Wennberg, A Lozano
International journal of neural systems 19 (03), 213-226, 2009
|Response to clozapine in a clinically identifiable subtype of schizophrenia|
NJ Butcher, WLA Fung, L Fitzpatrick, A Guna, DM Andrade, AE Lang, ...
The British Journal of Psychiatry 206 (6), 484-491, 2015
|Dravet syndrome: Seizure control and gait in adults with different SCN1A mutations|
JJ Rilstone, FM Coelho, BA Minassian, DM Andrade
Epilepsia 53 (8), 1421-1428, 2012
|Epilepsy: transition from pediatric to adult care. Recommendations of the Ontario epilepsy implementation task force|
DM Andrade, AS Bassett, E Bercovici, F Borlot, E Bui, P Camfield, ...
Epilepsia 58 (9), 1502-1517, 2017